Moderna Inc. (MRNA) Social Stream



Moderna Inc. (MRNA): $103.29

3.02 (+3.01%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add MRNA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#127 of 359

in industry

MODERNA INC (MRNA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering MODERNA INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 15 $475 $86 $245.923 $100.27 145.26%
2021-11-26 14 $475 $86 $257.333 $100.27 156.64%
2021-12-10 14 $475 $86 $256.769 $100.27 156.08%
2021-12-20 13 $475 $86 $256.769 $100.27 156.08%
2022-01-03 13 $475 $86 $254.846 $100.27 154.16%
2022-01-10 13 $506 $86 $257.23 $100.27 156.54%
2022-01-18 13 $506 $86 $257.384 $100.27 156.69%
2022-01-21 14 $506 $86 $250.857 $100.27 150.18%
2022-01-27 14 $506 $86 $249.071 $100.27 148.4%
2022-01-31 14 $506 $85 $245.428 $100.27 144.77%
2022-02-22 14 $506 $85 $245.307 $100.27 144.65%
2022-02-25 14 $506 $85 $244.538 $100.27 143.88%
2022-03-18 14 $506 $81 $240.384 $100.27 139.74%
2022-03-25 14 $506 $81 $241.153 $100.27 140.5%
2022-04-07 14 $506 $80 $241.077 $100.27 140.43%
2022-05-04 14 $506 $80 $241.384 $100.27 140.73%
2022-05-11 14 $506 $80 $237.307 $100.27 136.67%
2022-05-23 14 $506 $80 $225.461 $100.27 124.85%
2022-06-16 14 $506 $70 $224.692 $100.27 124.09%
2022-07-29 11 $506 $70 $229.416 $100.27 128.8%
2022-08-01 12 $506 $77 $235.909 $100.27 135.27%
2022-08-03 12 $506 $77 $230 $100.27 129.38%
2022-08-04 12 $506 $74 $230.416 $100.27 129.8%
2022-08-30 11 $506 $74 $230.416 $100.27 129.8%
2022-10-12 12 $506 $74 $230.416 $100.27 129.8%
2022-10-13 13 $506 $74 $233.153 $100.27 132.53%
2022-10-18 13 $506 $74 $231.461 $100.27 130.84%
2022-10-21 13 $506 $74 $229.923 $100.27 129.3%
2022-11-03 13 $506 $101 $227.153 $100.27 126.54%
2022-11-04 13 $506 $101 $210.583 $100.27 110.02%
2022-11-08 14 $506 $101 $208.692 $100.27 108.13%
2022-11-10 14 $506 $101 $202.416 $100.27 101.87%
2022-11-14 14 $506 $101 $204.25 $100.27 103.7%
2022-11-15 14 $506 $101 $206.75 $100.27 106.19%
2022-12-13 14 $506 $101 $207.75 $100.27 107.19%
2022-12-14 14 $506 $102 $208.25 $100.27 107.69%
2022-12-16 14 $506 $102 $211.5 $100.27 110.93%
2022-12-19 14 $506 $102 $220.25 $100.27 119.66%
2023-01-03 14 $506 $102 $220.5 $100.27 119.91%
2023-01-09 14 $506 $102 $221.583 $100.27 120.99%
2023-01-17 14 $506 $102 $224.916 $100.27 124.31%
2023-01-20 14 $506 $111 $227.083 $100.27 126.47%
2023-01-23 13 $506 $111 $227.636 $100.27 127.02%
2023-01-24 13 $506 $111 $227.272 $100.27 126.66%
2023-01-26 13 $506 $111 $229.09 $100.27 128.47%
2023-02-08 13 $506 $111 $230.09 $100.27 129.47%
2023-02-24 13 $506 $111 $228.272 $100.27 127.66%
2023-02-26 13 $506 $93 $226.363 $100.27 125.75%
2023-03-01 13 $506 $93 $223.09 $100.27 122.49%
2023-03-02 14 $506 $93 $221.166 $100.27 120.57%
2023-04-11 14 $506 $93 $223.666 $100.27 123.06%
2023-04-21 14 $430 $93 $218.416 $100.27 117.83%
2023-05-03 15 $430 $93 $218.416 $100.27 117.83%
2023-05-05 15 $430 $93 $217.583 $100.27 117%
2023-06-06 15 $430 $93 $213.25 $100.27 112.68%
2023-06-13 15 $430 $82 $212.333 $100.27 111.76%
2023-06-22 14 $430 $82 $218.909 $100.27 118.32%
2023-07-05 15 $430 $82 $216.583 $100.27 116%
2023-07-12 15 $430 $82 $214.5 $100.27 113.92%
2023-07-21 15 $430 $82 $205.461 $100.27 104.91%
2023-07-24 16 $430 $82 $200.52 $100.27 99.98%
2023-08-02 16 $430 $82 $199.805 $100.27 99.27%
2023-08-04 16 $430 $82 $192.343 $100.27 91.83%
2023-08-07 16 $430 $82 $181.986 $100.27 81.5%
2023-08-08 16 $430 $82 $181.272 $100.27 80.78%
2023-09-13 16 $430 $68 $180.272 $100.27 79.79%
2023-09-27 16 $430 $66 $180.129 $100.27 79.64%

The Trend in the Analyst Price Target


MRNA's average price target has moved down $30.45 over the prior 47 weeks.

Over the past 50 weeks, MRNA's average upside potential has been 55.33%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-05 15 430 93 213.250 137.04 55.61%
2023-06-06 15 430 93 213.250 126.90 68.05%
2023-07-21 15 430 82 205.461 126.43 62.51%
2023-08-01 16 430 82 199.805 113.94 75.36%
2023-08-23 16 430 68 180.272 115.46 56.13%

MRNA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.31 6 1 8 1 1 16

The Trend in the Broker Recommendations


MRNA's average broker recommendation rating improved by 0.12 over the prior 16 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MRNA as an investment opportunity.

  • MRNA has a lower variance in analysts' estimates than -7117.84% of all US stocks.
  • MRNA has a greater average analyst price target than 6975.94% of Pharmaceutical Products stocks.
  • In terms of how MODERNA INC fares relative to stocks in the large market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 6597.83% of that group.
  • In terms of how MODERNA INC fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is higher than 6314.66% of that group.

In the Pharmaceutical Products industry, DNLI, ARGX, and CRSP are the three stocks most similar to MODERNA INC regarding the price target and analyst recommendation information presented here.

Is MRNA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!